Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients
- PMID: 1424275
- PMCID: PMC1554608
Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients
Abstract
Chronic Pseudomonas aeruginosa lung infection is the leading cause of death in patients with cystic fibrosis (CF). Poor prognosis correlates with a high number of anti-pseudomonas precipitins and with high levels of IgG2 and IgG3 anti-pseudomonas antibodies. Reports of several highly significant associations between certain Gm (genetic markers of IgG on human chromosome 14) and Km (k-type light chain determinants on chromosome 2) phenotypes and immune responsiveness to various antigens suggest that allotype-linked immune response genes do exist in man. Furthermore correlation between Gm types and IgG subclass levels has been reported. A group of 143 CF patients were investigated (31 non-infected and 112 chronic infected). The IgG subclass antibodies to three different P. aeruginosa antigens (P. aeruginosa standard antigen (St-Ag), alginate and LPS) were determined. Immunoglobulin allotypes were determined by haemagglutination inhibition. Samples were typed for G1m(1,2,3, and 17), G2m(23), G3m(5,21), and Km(1,3). Statistical analysis of our data demonstrate that IgG3 anti-pseudomonas antibody levels and Gm markers are related. IgG3 antibody levels to all investigated P. aeruginosa antigens are significantly higher in sera homozygous for Gm(3;5), somewhat lower in heterozygous sera, and significantly lower in sera homozygous for Gm(1,2,17;21). We suggest that genetic differences between the patients may explain the present differences in subclass patterns.
Similar articles
-
Immunoglobulin allotypes and IgG subclass antibody response to Aspergillus fumigatus in cystic fibrosis patients.J Cyst Fibros. 2004 Aug;3(3):173-8. doi: 10.1016/j.jcf.2004.05.048. J Cyst Fibros. 2004. PMID: 15463904
-
Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.J Clin Invest. 1989 Dec;84(6):1794-804. doi: 10.1172/JCI114364. J Clin Invest. 1989. PMID: 2512330 Free PMC article.
-
The influence of allotypes on the IgG subclass response to chromosomal beta-lactamase of Pseudomonas aeruginosa in cystic fibrosis patients.Clin Exp Immunol. 1997 Apr;108(1):88-94. doi: 10.1046/j.1365-2249.1997.d01-994.x. Clin Exp Immunol. 1997. PMID: 9097916 Free PMC article.
-
IgG subclasses and chronic bacterial infection. Subclass antibodies and the clinical course of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.APMIS Suppl. 1996;66:1-41. APMIS Suppl. 1996. PMID: 8972694 Review. No abstract available.
-
Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.APMIS Suppl. 2003;(116):1-47. APMIS Suppl. 2003. PMID: 14692154 Review.
Cited by
-
Immunoglobulin GM and KM allotypes are associated with antibody responses to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients.J Cyst Fibros. 2021 Nov;20(6):1080-1084. doi: 10.1016/j.jcf.2021.06.011. Epub 2021 Jul 7. J Cyst Fibros. 2021. PMID: 34246573 Free PMC article.
-
The p.Arg435His Variation of IgG3 With High Affinity to FcRn Is Associated With Susceptibility for Pemphigus Vulgaris-Analysis of Four Different Ethnic Cohorts.Front Immunol. 2018 Aug 2;9:1788. doi: 10.3389/fimmu.2018.01788. eCollection 2018. Front Immunol. 2018. PMID: 30116249 Free PMC article.
-
Specific IgG2 antibodies to Pseudomonas aeruginosa lipid A and lipopolysaccharide are early markers of chronic infection in patients with cystic fibrosis.Infection. 1993 Sep-Oct;21(5):297-302. doi: 10.1007/BF01712448. Infection. 1993. PMID: 8300245
-
Epistatic effects of immunoglobulin GM and KM allotypes on outcome of infection with hepatitis C virus.J Virol. 2004 May;78(9):4561-5. doi: 10.1128/jvi.78.9.4561-4565.2004. J Virol. 2004. PMID: 15078937 Free PMC article.
-
Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine.Infect Immun. 1994 Sep;62(9):3972-9. doi: 10.1128/iai.62.9.3972-3979.1994. Infect Immun. 1994. PMID: 8063415 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical